ABSTRACT: The RNase H cleavage potential of the RNA strand basepaired with the complementary antisense oligonucleotides (AONs) containing North-East conformationally constrained 1′,2′-methylene-bridged (azetidine-T and oxetane-T) nucleosides, North-constrained 2′,4′-ethylene-bridged (aza-ENA-T) nucleoside, and 2′-alkoxy modified nucleosides (2′-O-Me-T and 2′-O-MOE-T modifications) have been evaluated and compared under identical conditions. When compared to the native AON, the aza-ENA-T modified AON/RNA hybrid duplexes showed an increase of melting temperature (∆T m ) 2.5-4°C per modification), depending on the positions of the modified residues. The azetidine-T modified AONs showed a drop of 4-5.5°C per modification with respect to the native AON/RNA hybrid, whereas the isosequential oxetane-T modified counterpart, showed a drop of ∼5-6°C per modification. The 2′-O-Me-T and 2′-O-MOE-T modifications, on the other hand, showed an increased of T m by 0.5°C per modification in their AON/ RNA hybrids. All of the partially modified AON/RNA hybrid duplexes were found to be good substrates for the RNase H mediated cleavage. The K m and V max values obtained from the RNA concentrationdependent kinetics of RNase H promoted cleavage reaction for all AON/RNA duplexes with identical modification site were compared with those of the reference native AON/RNA hybrid duplex. The catalytic activities (K cat ) of RNase H were found to be greater (∼1.4-2.6-fold) for all modified AON/RNA hybrids compared to those for the native AON/RNA duplex. However, the RNase H binding affinity (1/K m ) showed a decrease (∼1.7-8.3-fold) for all modified AON/RNA hybrids. This resulted in less effective (∼1.1-3.2-fold) enzyme activity (K cat /K m ) for all modified AON/RNA duplexes with respect to the native counterpart. A stretch of five to seven nucleotides in the RNA strand (from the site of modifications in the complementary modified AON strand) was found to be resistant to RNase H digestion (giving a footprint) in the modified AON/RNA duplex. Thus, (i) the AON modification with azetidine-T created a resistant region of five to six nucleotides, (ii) modification with 2′-O-Me-T created a resistant stretch of six nucleotides, (iii) modification with aza-ENA-T created a resistant region of five to seven nucleotide residues, whereas (iv) modification with 2′-O-MOE-T created a resistant stretch of seven nucleotide residues. This shows the variable effect of the microstructure perturbation in the modified AON/RNA heteroduplex depending upon the chemical nature as well as the site of modifications in the AON strand. On the other hand, the enhanced blood serum as well as the 3′-exonuclease stability (using snake venom phosphodiesterase, SVPDE) showed the effect of the tight conformational constraint in the AON with aza-ENA-T modifications in that the 3′-exonuclease preferentially hydrolyzed the 3′-phosphodiester bond one nucleotide away (n + 1) from the modification site (n) compared to all other modified AONs, which were 3′-exonuclease cleaved at the 3′-phosphodiester of the modification site (n). The aza-ENA-T modification in the AONs made the 5′-residual oligonucleotides (including the n + 1 nucleotide) highly resistant in the blood serum (remaining after 48 h) compared to the native AON (fully degraded in 2 h). On the other hand, the 5′-residual oligonucleotides (including the n nucleotide) in azetidine-T, 2′-O-Me-T, and 2′-O-MOE-T modified AONs were more stable compared to that of the native counterpart but more easily degradable than that of aza-ENA-T containing AONs.
RNA part of AON/RNA hybrid duplexes (1) . The second strategy has essential advantages over the steric blocking because it requires only a relatively small amount of AON for catalytic turnovers. The permanent destruction of the target RNA message with catalytic turnover may provide enough lifetime in cells (2) for the AON to act as a potential drug provided the AON has sufficient stability in the blood serum and is capable of penetrating in the cell (Delivery). Considerable attention has been directed toward the chemical design of AONs that would enhance the target affinity, specificity, capability to recruit RNase H, and nuclease stability. The first generation of AONs, phosphorothioate DNA analogues, showed an increase of the nucleases resistance, but their therapeutic potential was limited due to low binding affinity to the target RNA, less sequence specificity, and strong affinity to the heparin-binding proteins (3, 4) . Reduction of toxicity with enhanced binding affinity was achieved by the second generation of AONs based on a mixed backbone oligonucleotides (5) , involving 2′-O-alkyl modifications, 2′-O-alkyl modifications with glycol ether linkages, and 2′-F and 2′-O-aminoalkyl modifications (6) (7) (8) . The disadvantage of these chimeric oligonucleotides was that they have poor nuclease stability (9) as well as low RNase H recruitment and cleavage capability (7, 8) . AONs containing boranophosphates (10) and methylphosphonates (11) enhanced RNase H activity, whereas binding affinity to the target RNA was not significantly improved.
The AONs with one or more conformationally locked nucleoside residues have also been an area of considerable interest (12) (13) (14) (15) (16) (17) (18) (19) . Introduction of conformationally constrained nucleotides can make the AON strand locked to mimic the DNA-or RNA-type conformation (1, 20) . It is known that for eliciting RNase H activity (2, 21) the AON in the AON/RNA hybrid duplex should retain the B-type DNA conformation with the South-type sugar; at the same time the RNA moiety should retain its A-type helix character with the North-type sugar (22) . Incorporation of a conformationally preorganized North-type nucleotide into an oligodeoxynucleotide modulates the thermal stability of the AON/RNA duplex depending upon the type of conformational constraint. For example, each locked nucleic acid (LNA) (23, 24) residue increases the T m by 4-8°C per modification, each oxetane-T (25, 26) or azetidine-T (27) moiety reduce the T m by 4-6°C per modification but no change in the T m for oxetane-A and oxetane-G residues (28) . The ability of these North-type conformationally constrained AONs is that the local conformational change is transmitted to the neighboring nucleotides in the AON (29) to transform a small stretch of the AON strand to the RNA-type. This essentially produces an RNA/RNA-type duplex, which is not cleaved by RNase H, thereby showing the footprints in the RNase H cleavage reaction of the heteroduplex (1, 25, 26, 30) . Thus, LNA-modified AONs showed high affinity to the target RNA, and the gapmer of LNA/RNA heteroduplexes required gaps of 7-8 native deoxynucleotides between LNA moieties to elicit RNase H activity (31) . In the case of conformationally constrained oxetane-modified AONs (25, 26, (28) (29) (30) , a gap of only five nucleotides is needed to regain the RNase H eliciting capability compared to seven to eight nucleotides for the LNA.
To improve the design principle of the AON strand, clearly we need to understand how the introduction of various 2′-substituents modulate the preorganization of the AON strand and the AON/RNA duplex for the recruitment of RNase H, as well as give the AON strand adequate stability toward cellular nucleases. We report here the RNase H cleavage properties and kinetics of AON/RNA duplexes with 2′-OMe-T, 2′-O-MOE-T modifications (B and C in Figure 1 ) and compare their RNase H cleavage properties with those of the conformationally constrained modifications in the sugar moiety involving 1′,2′-methylene bridged [azetidine-T (D) and oxetane-T (E) in Figure 1 ] (25, 27) with a NorthEast-type sugar conformation and 2′,4′-ethylene bridged nucleoside, aza-ENA-T (A in Figure 1 ) (32), with a Northconstrained conformation. We show that each of these modifications shows uniquely different RNase H recruitment and cleavage properties, which potentially can open up new avenues for different applications. We also show here how the blood serum and the 3′-exonuclease (using snake venom phosphodiesterase, SVPDE) stability of the modified AON strand can be steered by effective change of the chemical nature of the substituent as well as its site in the AON strand.
MATERIALS AND METHODS

Materials. Escherichia coli
RNase H (5 units/µL, specific activity 420 000 units mg -1 , molecular weight 21 000 g mol -1 ), T4 polynucleotide kinase (30 units/µL), and [γ-32 P]-ATP were purchased from Amersham Pharmacia Biotech (Sweden). Phosphodiesterase I (Crotalus Adamanteus venom) and human serum (AB male) were from Sigma. Target RNA was from IBA BioTAGnology (Germany).
Oligonucleotide Synthesis. Azetidine-T (27), aza-ENA-T (32) (Scheme S1 and Experimental Section in Supporting Information), 2′-O-Me-T (33), and 2′-O-MOE-T (34, 35) modified nucleosides ( Figure 1) were synthesized following the previously reported procedures. Synthesis of modified oligonucleotides 1-11 and the complementary DNA (Table 1) was carried out using an Applied Biosystems 392 automated DNA/RNA synthesizer, as previously described (27) . AONs were purified by 20% polyacrylamide 7 M urea denaturing gel electrophoresis (PAGE), extracted with 0.3 M NaOAc, and desalted with C18-reverse phase cartridges. Purity of the products was greater than 95% as determined by PAGE.
UV Melting Experiments. Determination of the T m values of the AON/RNA or AON/DNA hybrid duplexes was carried out in a buffer, containing 60 mM Tris-HCl (pH 7.5), 60 mM KCl, 0.8 mM MgCl 2 , and 2 mM dithiothreitol (DTT). Absorbance was monitored at 260 nm in the temperature range from 20 to 70°C using a Lambda 40 UV spectrophotometer equipped with a Peltier temperature programmer with a heating rate of 1°C/min. Samples (mixture of 1 µM AON and 1 µM RNA or DNA) were denatured at 80°C for 5 min followed by slow cooling to 17°C prior to the measurements. T m values were obtained from the maxima of the first derivatives of the melting curves. All T m values given are the averages of three independent sets of experiments and are within a (0.2°C error range.
32 P Labeling of Oligonucleotides. The oligoribonucleotide and oligodeoxyribonucleotides were 5′-end labeled with 32 P using [γ-32 P]ATP and T4 polynucleotide kinase by a standard procedure. Labeled RNA and AONs were purified by 20% 7 M urea PAGE, and specific activities were measured using a Beckman LS 3801 counter.
RNase H Digestion Assay. Target 0.1 µM RNA (specific activity 50 000 cpm) and a 25-fold excess of AON were incubated in a buffer containing 20 mM Tris-HCl (pH 8.0), 20 mM KCl, 10 mM MgCl 2 , 0.1 mM EDTA, and 0.1 mM DTT at 21°C in the presence of 0.04 U E. coli RNase H. Prior to the addition of the enzyme, reaction components were preannealed in the reaction buffer by heating at 80°C for 5 min followed by 1.5 h equilibration at 21°C. Total reaction volume was 30 µL. Aliquots of 3 µL were removed after 7, 15, 35, and 60 min, and the reactions were terminated by mixing with stop solution (7 µL) containing 0.05 M EDTA, 0.05% (w/v) bromophenol blue, and 0.05% (w/v) xylene cyanole in 80% formamide. The samples were subjected to 20% 7 M urea PAGE and visualized by autoradiography.
To obtain the rate constants for RNaseH cleavage, three independent sets of experiments were performed with the target RNA (0.1 µM, specific activity 50 000 cpm) and a 25-fold excess of AON by incubating them in a buffer containing 20 mM Tris-HCl (pH 8.0), 20 mM KCl, 10 mM MgCl 2 , 0.1 mM EDTA, and 0.1 mM DTT at 21°C in the presence of 0.03 U E. coli RNase H. Aliquots of 3 µL were removed after 5, 10, 15, 20, 25, and 40 min, and the reactions were terminated by mixing with stop solution as described before. The samples were subjected to 20% 7 M urea PAGE and visualized by autoradiography. Quantitation of cleavage products was performed in each set of experiments using a Molecular Dynamics PhosphorImager. All values are averages and standard deviations of three independent experiments and are normalized. Method for Kinetic Analysis. The kinetic analysis of RNase H promoted cleavage of the AON/RNA duplex involves three distinct steps ( Figure 2 ): (i) the duplex formation, (ii) the duplex (i.e., substrate)-enzyme complex formation, and (iii) cleavage of the RNA substrate in the AON/RNA duplex, and formation of the product-enzyme complex.
According to the Michaelis-Menten equation, eq 1, the initial velocity (V 0 ) of the cleavage reaction depends on the concentration of the enzyme (E 0 ) and the substrate
where Equation 1 can be used for monitoring RNA cleavage kinetics by RNase H only when RNA is saturated by AON. In this case, we can consider that the substrate concentration is equal to the concentration of RNA. Also we assume that the initial velocity (V 0 ) is the rate of product formation only for the first few percentages when the products have not significantly accumulated and also the substrate concentration has not significantly changed. In this case, changes in RNA concentrations are linear with time.
To avoid the influence of thermal stabilities (T m 's) of the AON/RNA heteroduplexes [to minimize influence of K d ( Figure 2) ], all the kinetic experiments were performed at a temperature (21°C) much lower than the T m values of the duplexes and in saturated conditions.
From eq 1, initial velocity (V 0 ) in unsaturated conditions (S 0 e K m ) increases with an increase of substrate concentration (S 0 ) and has a saturation plateau when S 0 f ∞. Since we have used a wide range of RNA concentrations or, alternatively, substrate concentrations (S 0 ) the MichaelisMenten equation (eq 1) will have different forms under low and high substrate concentrations.
In the case of low substrate concentration (S 0 , K m ), eq 1 can be rewritten as eq 3:
Under these conditions, the initial velocity (V 0 ) is linearly dependent upon the substrate concentration (S 0 ) with the linear coefficient V max /K m .
Under high substrate concentration (S 0 . K m ), eq 1 takes the form of eq 4:
This means that the initial velocity (V 0 ) is dependent only on V max , or in other words, on K cat and E 0 .
3′-Exonuclease Degradation Studies. The stability of the AONs toward 3′-exonucleases was tested using snake venom phosphodiesterase (SVPDE) from Crotalus adamanteus. All reactions were performed at 3 µM DNA concentration (5′-end 32 P labeled with specific activity 50 000 cpm) in 56 mM Tris-HCl (pH 7.9) and 4.4 mM MgCl 2 at 21°C. Exonuclease concentration of 2.5 ng/µL was used for digestion of oligonucleotides. Total reaction volume was 14 µL. Aliquots of 3 µL were removed at 1/2, 1, 2, and 24 h and quenched with stop solution (0.05 M EDTA in 80% formamide). These samples were subjected to 20% 7 M urea PAGE and visualized by autoradiography. Quantitation of cleavage products was performed using a Molecular Dynamics PhosphorImager.
Stability Studies in Human Serum. 5′-End 32 P labeled oligonucleotides with specific activity 90 000 cpm at 2 µM FIGURE 2: Kinetic pathway for RNase H hydrolysis of an AON substrate. D is the AON; R is the target RNA; K d is the equilibrium constant of dissociation of the heteroduplex DR; E is RNase H enzyme; K s is the association constant of the substrate-enzyme complex DRE; K cat is the catalytic constant; DPE is the AONproduct-enzyme complex.
concentration were incubated in 26 µL of human serum (AB male) at 21°C. Total reaction volume was 36 µL. Aliquots (3 µL) were removed after 1/4, 1/2, 1, 2, 9 h (in another set of experiments, after 4, 10, 24, 34, 48 h) and quenched with 7 µL of stop solution (0.05 M EDTA in 80% formamide). They were resolved in 20% 7 M urea PAGE and visualized by autoradiography. The modified AON stability studies in the human serum were performed at least twice in each case.
RESULTS
(A) Binding Affinity of the Chimeric Antisense Oligonucleotides to the Target RNA and DNA. Incorporation of the single aza-ENA-T modification (A in Figure 1 ) to AON (entries 2-5 in Table 1 ) significantly enhances its affinity to complementary RNA (∆T m +2.5 to +4°C) depending upon the site of the modification in the AON strand. The different ∆T m values can be due to the site-dependency of the variable conformational preorganization dictated by the North-fused sugar moiety to the single-stranded AON. Single azetidine-T incorporation (D in Figure 1 ) enhances the T m of the AON/RNA duplex (entries 8-11 in Table 1 ) by ∼1°C compared to that of the isosequential oxetane-T modified hybrid duplex (25, 30) ; however this leads to a ∼4-5°C drop in T m with respect to the unmodified AON/RNA hybrid duplex. Incorporation of 2′-O-Me-T or 2′-O-MOE-T modifications (B and C in Figure 1 ) to AON (entries 6 and 7 in Table 1 ) did not change the target binding affinity significantly compared to the unmodified hybrid duplex. However, with complementary DNA, all modified AONs showed a significant drop in duplex melting (Table 1) (Table 1) were found to be good substrates for the E. coli RNase H with varying cleavage potential and patterns. All azetidine-T modified AONs 8-11/RNA duplexes showed a similar cleavage pattern as those of the isosequential oxetane-T modified duplexes ( Figure 3 , Supporting Information Figure S1 ) (25, 29, 30) . The RNase H mediated cleavage pattern of azetidine-T modified AON 8/RNA was found to be quite similar to the cleavage pattern of the native AON 1/RNA duplex except that there was no cleavage at the A5 and A6 positions. In the modified AONs 9-10/RNA hybrids with azetidine-T, five nucleotides toward the 3′-end from the site opposite to the modification were found to be insensitive toward RNase H promoted cleavage (Figure 3 ). On the other hand for the AON 11/RNA duplex, six nucleotides toward the 3′-end from the site opposite to the modification showed resistance toward the RNase H mediated cleavage. These observations are presumably owing to the local steric and structural alterations brought by the modification, thereby preventing the flexibility and accessibility required for the RNase H cleavage (1). However, in the case of aza-ENA-T modified AONs 2-5/RNA hybrid duplexes, the RNA cleavage patterns were found to be different from those of the isosequential azetidine-T modified AONs 8-11 and oxetane-T (25, 30) Figure S1 ).
To evaluate the RNase H cleavage potential of the modified hybrids (Table 1) Figure 6 ). Since V max ) E 0 K cat (E 0 is initial effective enzyme concentration), and for all of our concentration-dependent kinetic experiments the value of E 0 was identical, V max is thus proportional to K cat . The effective enzyme activity (K cat /K m ) for all chemically modified substrates was without exception lower than that for the native substrate (Table 5, Figure 7 ). These data showed that the catalytic constant (K cat ), which represents the maximum number of substrate molecules converted to products per active site per unit time (36) acid based therapeutics. As a result, many chemical modifications of natural DNA have been investigated for improvement of AON stability in vivo (37) (38) (39) (40) . To examine the effect of 3′-exonuclease on the chemically modified chimeric oligonucleotides, AONs 2-11 (Table 1) were tested against SVPDE. 32 P-labeled oligonucleotides were incubated with enzyme at 21°C for up to 24 h. Aliquots were removed at the appropriate time points to analyze the cleavage pattern (Figure 8 ). The unmodified AON 1 was completely degraded after 30 min, whereas the full length of aza-ENA-T (AONs 2-5) and azetidine-T (AON 8) still remained to certain extent (∼41, ∼14, ∼9, ∼6, and ∼21%, respectively). For 2′-OMe-T (AON 6), 2′-O-MOE-T (AON 7), and azetidine-T modified AONs 9-11 degradation went faster with respect to the isosequential aza-ENA-T (AON 2-5) (Figure 8) . Also, all aza-ENA-T modified AONs were cleaved by 3′-exonucleases at the phosphodiester linkage (n + 1) at the 3′-end, which is one nucleotide after the modification site (n) of the oligonucleotide. This is an interesting observation in view of the fact that the identical AON oligonucleotides with North-East constrained azetidine and oxetane (26) modifications were cleaved at the 3′-phosphodiester of the modification site (n) under the same conditions ( Figure 8 ). It is likely that the above difference in the 3′-exonuclease promoted cleavage sites reflects a tighter conformational constraint for aza-ENA-T residue in the modified AONs, compared to azetidine and oxetane modifications, such that the conformational hyperspace of the adjacent 3′-phosphodiesters (at n) adopts a conformation which prevents hydrolysis of the 3′-phosphodiester at the modification site (n). However, this effect of the tighter conformational constraint from aza-ENA-T at (n) vanishes at the (n + 1) phosphodiester linkage toward the 3′-end and is cleaved by 3′-exonuclease in a normal manner as for the (n) phosphodiester linkage of azetidine and oxetane modifications.
(E) Human Serum Stability of AON Chimeras. The stability of AONs was also checked against human serum, which contains mainly 3′-exonucleases (9). The digestion pattern was similar to that obtained from the digestion with SVPDE. When compared with the native AON 1, which was completely degraded after 2 h, ∼15-22% of full length of aza-ENA-T modified AONs 2-5 was left undegraded after the same period of time (Supporting Information, Figure S9 ). 
Biochemistry
2′-Alkoxy Modified Oligonucleotides G
For other AONs the behavior of exonuclease tolerance has been found to be similar to that of the digestion with SVPDE. Thus, after 2 h of digestion in human serum, the 2′-O-Me-T modified AON 6, 2′-O-MOE-T modified AON 7, and azetidine-T modified AONs 8-11 (Supporting Information, Figure S9 ) were found to be almost fully degraded. It should be noted that, similar to the SVPDE digestion, all aza-ENA-T modified AONs were cleaved by human serum at the phosphodiester linkage, which is one nucleotide after (n + 1) the aza-ENA-T modification site (n) toward the 3′-end. These 5′-residual oligonucleotides (including the n + 1 nucleotide) for aza-ENA-T modified AONs 2-5 as well as the 5′-residual oligonucleotide (including the n nucleotide) for azetidine-T modified AON 8 still remained in human serum after 48 h at 21°C (Figure 9 ). However, the 5′-residual oligonucleotides (including the n nucleotide) of the azetidine-T modified AONs 9 and 10 remained only up to 34 h under the same experimental condition. In contrast, the 5′-residual oligonucleotides (including the n nucleotide) of 2′-O-Me-T modified AON 6, 2′-O-MOE-T modified AON 7 and one of the azetidine-T modified AONs (AON 11) have been found to be stable only for 10 h (Figure 9 ).
DISCUSSION
The structural requirement of oligonucleotide hybrids to be recognized and to be cleaved by RNase H has been well studied. Many of the conformationally constrained nucleotides have been shown to enhance the stability of the modified AON/RNA heteroduplex, but they failed to show any RNase H recruiting capability (1, 6, 20, 23) . Increase in the affinity of AON toward target RNA without inducing RNase H activity does not give expected results for developing new antisense drugs (41) . It has emerged that for a modified AON/RNA heteroduplex to become a substrate for RNase H the functional groups present in the minor groove of the duplex should not inhibit binding of the enzyme. The 2′-OH group of the target RNA should be easily accessible to the enzyme, and the duplex should have enough flexibility to allow optimal RNase H cleavage activity (1, 42) .
Therefore, we investigated the ability of AON chimeras of different kinds to recruit RNase H. Chimeric oligonucleotides (Table 1) containing conformationally constrained residues [aza-ENA-T (A in Figure 1 ) and azetidine-T (D in Figure 1 )] and 2′-modifications [2′-O-Me-T (B in Figure 1 ) and 2′-O-MOE-T (C in Figure 1) ] at various positions in duplex with the complementary RNA were compared with the native as well as with the isosequential oxetane-T (E in Figure 1) (25, 29, 30 ) modified counterpart.
The binding affinity of the chimeric AONs to the target RNA was determined first. An increase of the binding affinity toward RNA in the case of aza-ENA-T modification was expected due to the incorporation of North-conformationally constrained sugar as it improves stacking between the nearest-neighbors (43) and thus minimizes the entropic energy penalty in the free-energy of stabilization for the duplex formation with RNA. This increase in T m for aza-ENA-T modified AONs 2-5 (2.5 to 4°C per modification) could also be attributed to the electrostatic interaction of 2′-amino function of aza-ENA-T with the neighboring phosphate at the physiological pH, which is known to lead to efficient duplex formation (44, 45) . This particular argument can also account for azetidine-T modified AON 11/RNA hybrid duplexes (∆T m ) -4) when compared to the isosequential oxetane-T modified AON 12/RNA hybrids (∆T m ) -5) ( Table 1) . As azetidine or oxetane analogues have North-East constrained sugars with anomeric carbon participating in the modification, the AON containing these analogues therefore could change the nucleobase orientation only to less efficient stacking between the nearest-neighbors, leading to the drop in T m toward the target RNA with respect to the unmodified AON/RNA hybrid.
To map the structural perturbation in the microenvironment owing to the modification in the variously modified AON/ RNA duplexes (Table 1 , Figure 1) , we determined the cleavage footprint of the complementary RNA strand by RNase H. Thus, the comparison of the RNase H cleavage pattern of the complementary RNA in AON/RNA heteroduplexes containing different modifications showed that the RNase H indeed can discriminate the local variations of the microstructure of the heteroduplex substrate brought about by incorporation of various modified residues in the AON. However, the global helical conformation of the AON/RNA Table 1 for the AON oligonucleotides) in human serum. Lanes 1-6 represent the time points taken after 0, 4, 10, 24, 34, and 48 h of incubation with serum.
hybrid duplexes with respect to the unmodified hybrid duplex was not changed, which was evident from the CD comparison (29, 30, 32) . We conclude that the resistant stretch of five ribonucleotides in the chimeric azetidine-T modified AONs 9-10/RNA and aza-ENA-T modified AON 3/RNA duplexes is created, as for isosequential oxetane-T AONs chimeras (30) , as a result of microstructure perturbation in those resistant stretches of the modified heteroduplexes compared to the regular native AON/RNA duplex. However, in the case of 2′-O-MOE-T modified AON 7/RNA and aza-ENA-T modified AON 5/RNA duplexes, a stretch of resistant seven nucleotides toward the 3′-end from the site opposite to the modification site were found due to the insensitiveness toward the RNase H promoted cleavage. In contrast, in the case of 2′-O-Me-T modified AON 6/RNA and azetidine-T modified AON 11/RNA duplexes, a resistant stretch of six nucleotides was found to be insensitive toward the RNase H cleavage (Figure 3) . These results suggest that the conformational preorganization of the single modified AONs depends on the type as well as on the site of incorporation of the modification in the AON strand, which in the heteroduplex form with the complementary RNA can transmit the conformational changes of the AON to the RNA strand. Interestingly, the resulting microstructure perturbations can be recognized by the enzyme in AON/RNA hybrids in a variable manner depending upon the type and site of modifications in the AON strand.
Observed reaction rates from pseudo-first-order kinetics for the RNase H cleavage of RNA strand in the modified AON/RNA hybrid duplexes (Tables 2 and 3) showed that aza-ENA-T modified AON 3 (k rel ≈ 1.5) and azetidine-T modified AON 8 (k rel ≈ 1.4) were the most efficient for activation of RNase H, while aza-ENA-T modified AON 2 (k rel ≈ 0.8) induced slightly slower cleavage compared with that of the native AON 1/RNA duplex (k rel ) 1). The observed reaction rate in the case of aza-ENA-T modified AON 4 (k rel ≈ 1) was found to be the same as native AON 1/RNA duplex. AONs containing 2′-O-Me-T (AON 6, k rel ≈ 1.3), 2′-O-MOE-T (AON 7, k rel ≈ 1.1), azetidine-T (AONs 9, k rel ≈ 1.2; 10, k rel ≈ 1.3 and 11, k rel ≈ 1.1), and aza-ENA-T (AON 5, k rel ≈ 1.2) showed slightly faster relative rates than for the native AON 1/RNA duplex. Thus, the pseudo-first-order reaction rate constants suggest in general that the incorporation of a single modification to the AON leads to RNase H digestion as good as or better than the native AON except for one, AON 2.
Therefore, to evaluate the effect of different sugar modifications on the RNase H activity a detailed MichaelisMenten kinetics was carried out for the isosequential AONs containing aza-ENA-T (AON 5), azetidine-T (AON 11), 2′-O-Me-T (AON 6), 2′-O-MOE-T (AON 7) modifications, which are then compared with the native AON 1/RNA hybrid, as the standard. Kinetic data showed an expected decrease in effective enzyme activity for all modified AON/ RNA hybrids (Table 5, Figure 7) . The 2′-OH of the RNA which is stereochemically located in the minor groove of the AON/RNA hybrid duplex plays important role in the RNA cleavage reaction (1) . Therefore, the site for the RNase H catalytic cleavage activity is highly sensitive toward conformational changes as well as toward which substituent is stereochemically oriented at the minor groove. Introduction of conformationally constrained nucleotides or 2′-alkoxy modification in the AON strand of AON/RNA hybrid duplex made the minor groove irresponsive to the structural adjustment required for recognition and interaction by RNase H. Also, the introduction of a single positively charged 2′-propoxyamine modification into the chimeric AON portion of the heteroduplex substrate resulted in decreased RNase H binding affinity (8) . Electrostatic interaction between the positively charged modification and the enzyme can be responsible for the reduction in binding affinity. Therefore, the decrease of the enzyme binding affinity and a resulting loss in the effective enzyme activity for azetidine-T modified AON 5/RNA hybrid in comparison with the oxetane-T (26) counterpart AON 12/RNA can be attributed to the ability of the endocyclic 2′-amino function of azetidine-T to be protonated at the physiological pH (27) (pK a of 6.07). A similar reason may also be responsible in the case of aza-ENA-T modified AON 5, in comparison with its analogous ENA (46) modified AON, as the endocyclic aza-ENAnitrogen can also be protonated at the physiological pH (32), even more efficiently (pK a of 6.66) than the azetidine-T (pK a of 6.07).
To check the influence of modification incorporated to the AON on its resistance to nucleolytic degradation, chimeric AONs 2-11 were tested with SVPDE and human serum. In both cases, the enzyme digestion pattern for AONs was found to be similar (Figures 8 and 9 ). Even though the oligomers were not end-blocked, ∼6 to 41% (when digested with SVPDE) and ∼15 to 22% (when digested with human serum) of the full length of AONs 2-5 containing aza-ENA-T modification remained after 2 h, depending on the incorporation site of the modification to the AON, whereas native AON 1 was completely degraded (Figure 8 , Supporting Information Figure S9 ). On the other hand, all of the aza-ENA-T modified AONs 2-5 were cleaved by 3′-exonucleases only at the phosphodiester linkage at one nucleotide after (n + 1) the modification site (n) toward the 3′-end, and the 5′-residual oligonucleotides (including the n + 1 residue) still remained in human serum after 48 h ( Figure 9 ). In contrast, all azetidine-T modified AONs (AON  8-11 ), 2′-O-Me (AON 6) and 2′-O-MOE (AON 7) modified AONs were cleaved at the 3′-phosphodiester of the modification site (n) toward the 3′-end. However, these 5′-residual oligonucleotides (including n) showed lower stability toward the human serum compared to those of the aza-ENA-T modified AONs 2-5 (including n + 1 residue), except for azetidine-T modified AONs 8 (5′-residual oligonucleotide including n was remaining after 48 h). The 5′-residual oligonucleotides (including n) for the azetidine-T modified AONs 9-10 were found to be less stable (remaining after 34 h) in the human serum, whereas 5′-residual oligonucleotides (including n) for the azetidine-T modified AON 11, 2′-O-Me-T modified AON 6, and 2′-O-MOE-T modified AON 7 were found to be the least stable (remaining only until ∼10 h) in it among all modified AONs used in this study ( Figure 9) .
The above results suggest that conformational effect of the aza-ENA-T modification in the AON chimeras is transmitted toward the 3′-end and recognized by 3′-exonucleases. This influence of the aza-ENA-T when only a single modification at second position from the 3′-end of AON can give significant stability toward 3′-exonucleases can be used for further design of aza-ENA-T modified AONs.
In this study, chimeric oligonucleotides containing different modified units were evaluated for the RNase H cleavage potential of the RNA strand in AON/RNA hybrid duplex, their relative stability in blood serum and in the presence of 3′-exonuclease (SVPDE). To achieve the goal for efficient antisense-based therapeutics we need to find a balance between a high target affinity, better RNase H recruitment, and higher stability in the presence of cellular nucleases.
All of the chimeric AONs, except AON 11, with conformationally constrained nucleotides showed higher 3′-exonuclease stability compared to the 2′-alkoxy modified AONs. For the recruitment of the RNase H in the AON/RNA hybrid duplexes chimeric AONs with 2′-O-Me-T and oxetane-T modifications were found to be better substrates than the AONs containing 2′-O-MOE-T, azetidine-T, and aza-ENA-T at the same modification site. If binding to the target RNA is rate limiting (7), the increase in affinity to the target RNA with less efficient cleavage would have better results than high enzyme activity and loss in duplex stability. Therefore, the aza-ENA-T modified AONs is a promising antisense agent compared to the other North-East constrained and 2′-alkoxy modified counterparts mainly because (i) it shows higher affinity to the complementary target RNA; (ii) it is found to be a good substrate but with less effective enzyme activity for the RNase H; and (iii) it also shows improved resistance toward nucleases, which is one of the most desired requirements for antisense technology.
